Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Varian, Inc. (commonly known as Varian Instruments) was a leading global provider of scientific instruments and vacuum technologies for the life sciences, environmental, and industrial markets. Spun off from Varian Associates in 1999, the company specialized in high-performance analytical tools including nuclear magnetic resonance (NMR), mass spectrometry, and chromatography systems. These products were essential for pharmaceutical drug discovery, chemical analysis, and academic research. In 2010, Varian, Inc. was acquired by Agilent Technologies for approximately $1.5 billion, a move that significantly bolstered Agilent's portfolio in spectroscopy and vacuum products. Today, its legacy technologies are integrated into Agilent's broader analytical chemistry and life sciences divisions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Varian Instruments.